ABVC BioPharma, Inc. (ABVC)
0.91
-0.01
(-0.86%)
USD |
NASDAQ |
Oct 19, 14:07
ABVC BioPharma Cash from Operations (Annual) : -2.986M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -2.986M |
| December 31, 2024 | -1.809M |
| December 31, 2023 | -4.187M |
| December 31, 2022 | -7.638M |
| December 31, 2021 | -7.280M |
| December 31, 2020 | -6.042M |
| December 31, 2019 | -3.308M |
| December 31, 2018 | -2.255M |
| December 31, 2017 | -3.955M |
| September 30, 2016 | -3.475M |
| September 30, 2015 | -0.0007M |
| September 30, 2014 | -0.0056M |
| Date | Value |
|---|---|
| September 30, 2013 | -0.0378M |
| September 30, 2012 | -1.520M |
| September 30, 2011 | -1.593M |
| September 30, 2010 | -1.047M |
| September 30, 2009 | -1.556M |
| September 30, 2008 | -2.336M |
| September 30, 2007 | -2.693M |
| September 30, 2006 | -0.545M |
| September 30, 2005 | -0.0817M |
| December 31, 2004 | -0.0074M |
| December 31, 2003 | 0.0004M |
| December 31, 2002 | -0.013M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Anika Therapeutics, Inc. | 11.19M |
| Perspective Therapeutics, Inc. | -82.48M |
| MiMedx Group, Inc. | 74.00M |
| Abbott Laboratories | 9.566B |
| AngioDynamics, Inc. | 3.089M |